Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to dateDrug design, development and therapy, 2018-01, Vol.12, p.2539-2552 [Peer Reviewed Journal]COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 King et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S150043 ;PMID: 30147301Full text available |
|
2 |
Material Type: Article
|
Dexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative ReviewClinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.1019-1045 [Peer Reviewed Journal]2022 Kishore et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022 Kishore et al. 2022 Kishore et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S209395 ;PMID: 35418744Full text available |
|
3 |
Material Type: Article
|
Effectiveness of the Use of Three-Dose Intravitreal Ziv-Aflibercept in the Management of Diabetic Macular Edema in a Real-Life SettingClinical ophthalmology (Auckland, N.Z.), 2023-01, Vol.17, p.1129-1135 [Peer Reviewed Journal]2023 Munayco-Guillén et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Munayco-Guillén et al. 2023 Munayco-Guillén et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S398359 ;PMID: 37077223Full text available |
|
4 |
Material Type: Article
|
Prognosis of Ischemic Stroke Patients Undergoing Endovascular Thrombectomy is Influenced by Systemic Inflammatory Index Through Malignant Brain EdemaClinical interventions in aging, 2022-01, Vol.17, p.1001-1012 [Peer Reviewed Journal]COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Ji et al. 2022 Ji et al. ;ISSN: 1178-1998 ;ISSN: 1176-9092 ;EISSN: 1178-1998 ;DOI: 10.2147/CIA.S365553 ;PMID: 35814350Full text available |
|
5 |
Material Type: Article
|
Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical EndeavorClinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.661-669 [Peer Reviewed Journal]2021 Elfalah et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Elfalah et al. 2021 Elfalah et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S289068 ;PMID: 33628009Full text available |
|
6 |
Material Type: Article
|
The efficacy and safety of aflibercept and conbercept in diabetic macular edemaDrug design, development and therapy, 2018-01, Vol.12, p.3471-3483 [Peer Reviewed Journal]2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Cai et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S177192 ;PMID: 30410308Full text available |
|
7 |
Material Type: Article
|
Faricimab for Treatment-Resistant Diabetic Macular EdemaClinical ophthalmology (Auckland, N.Z.), 2022-08, Vol.16, p.2797-2801 [Peer Reviewed Journal]COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Rush and Rush. 2022 Rush and Rush. ;ISSN: 1177-5483 ;ISSN: 1177-5467 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S381503 ;PMID: 36042912Full text available |
|
8 |
Material Type: Article
|
The Effect of Anti-Vascular Endothelial Growth Factor on Retinal Microvascular Changes in Diabetic Macular Edema Using Swept-Source Optical Coherence Tomography AngiographyClinical ophthalmology (Auckland, N.Z.), 2020-01, Vol.14, p.3871-3880 [Peer Reviewed Journal]2020 Pongsachareonnont et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Pongsachareonnont et al. 2020 Pongsachareonnont et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/opth.s270410 ;PMID: 33235428Full text available |
|
9 |
Material Type: Article
|
Suprachoroidal versus Intravitreal Triamcinolone Acetonide for the Treatment of Diabetic Macular EdemaClinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.733-746 [Peer Reviewed Journal]2022 Zakaria et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022 Zakaria et al. 2022 Zakaria et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S351853 ;PMID: 35300032Full text available |
|
10 |
Material Type: Article
|
Two-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular EdemaClinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.603-609 [Peer Reviewed Journal]2022 Tran et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;Distributed under a Creative Commons Attribution 4.0 International License ;2022 Tran et al. 2022 Tran et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S352152 ;PMID: 35310546Full text available |
|
11 |
Material Type: Article
|
Optical Coherence Tomography Angiography Biomarkers Predict Anatomical Response to Bevacizumab in Diabetic Macular EdemaDiabetes, metabolic syndrome and obesity, 2022-01, Vol.15, p.395-405 [Peer Reviewed Journal]2022 Elnahry et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Elnahry et al. 2022 Elnahry et al. ;ISSN: 1178-7007 ;EISSN: 1178-7007 ;DOI: 10.2147/DMSO.S351618 ;PMID: 35177916Full text available |
|
12 |
Material Type: Article
|
Changes of Optical Coherence Tomography Biomarkers in Macular Edema Secondary to Retinal Vein Occlusion After Anti-VEGF and Anti-Inflammatory TherapiesDrug design, development and therapy, 2022-03, Vol.16, p.717-725 [Peer Reviewed Journal]2022 Ding et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022 Ding et al. 2022 Ding et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S351683 ;PMID: 35313554Full text available |
|
13 |
Material Type: Article
|
Managing Diabetic Macular Edema in Clinical Practice: Systematic Review and Meta-Analysis of Current Strategies and Treatment OptionsClinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.375-385 [Peer Reviewed Journal]2021 Veritti et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Veritti et al. 2021 Veritti et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S236423 ;PMID: 33551641Full text available |
|
14 |
Material Type: Article
|
Theaflavin alleviates inflammatory response and brain injury induced by cerebral hemorrhage via inhibiting the nuclear transcription factor kappa β-related pathway in ratsDrug design, development and therapy, 2018-01, Vol.12, p.1609-1619 [Peer Reviewed Journal]2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Fu et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S164324 ;PMID: 29928110Full text available |
|
15 |
Material Type: Article
|
Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trialsClinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10 (Issue 1), p.1103-1110 [Peer Reviewed Journal]COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Dugel et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S100764 ;PMID: 27366049Full text available |
|
16 |
Material Type: Article
|
Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edemaClinical interventions in aging, 2013-01, Vol.8, p.467-483 [Peer Reviewed Journal]COPYRIGHT 2013 Dove Medical Press Limited ;COPYRIGHT 2013 Dove Medical Press Limited ;2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Fong and Lai, publisher and licensee Dove Medical Press Ltd 2013 ;ISSN: 1178-1998 ;ISSN: 1176-9092 ;EISSN: 1178-1998 ;DOI: 10.2147/CIA.S36811 ;PMID: 23766636Full text available |
|
17 |
Material Type: Article
|
Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective AnalysisClinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.253-260 [Peer Reviewed Journal]2021 Pessoa et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Pessoa et al. 2021 Pessoa et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S280644 ;PMID: 33519187Full text available |
|
18 |
Material Type: Article
|
Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema in Eyes with Branch Retinal Vein Occlusion with vs Without Glaucoma – Does Glaucoma Affect Visual Outcome in Eyes with BRVO-ME After antiVEGF Injections?Clinical ophthalmology (Auckland, N.Z.), 2022-07, Vol.16, p.2275-2283 [Peer Reviewed Journal]COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Asami et al. 2022 Asami et al. ;ISSN: 1177-5483 ;ISSN: 1177-5467 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S356727 ;PMID: 35872969Full text available |
|
19 |
Material Type: Article
|
Photobiomodulation Therapy for Age-Related Macular Degeneration and Diabetic Retinopathy: A ReviewClinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.3709-3720 [Peer Reviewed Journal]2021 Muste et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Muste et al. 2021 Muste et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S272327 ;PMID: 34511875Full text available |
|
20 |
Material Type: Article
|
Vitrectomy for center-involved diabetic macular edemaClinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10 (Issue 1), p.735-742 [Peer Reviewed Journal]COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Browning et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/opth.s104906 ;PMID: 27175056Full text available |